These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 35090094)
1. Multi-omic landscaping of human midbrains identifies disease-relevant molecular targets and pathways in advanced-stage Parkinson's disease. Caldi Gomes L; Galhoz A; Jain G; Roser AE; Maass F; Carboni E; Barski E; Lenz C; Lohmann K; Klein C; Bähr M; Fischer A; Menden MP; Lingor P Clin Transl Med; 2022 Jan; 12(1):e692. PubMed ID: 35090094 [TBL] [Abstract][Full Text] [Related]
2. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms. Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498 [TBL] [Abstract][Full Text] [Related]
3. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease. Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501 [TBL] [Abstract][Full Text] [Related]
4. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model. Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355 [TBL] [Abstract][Full Text] [Related]
5. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease. He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539 [TBL] [Abstract][Full Text] [Related]
6. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients. Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338 [TBL] [Abstract][Full Text] [Related]
7. Role and Dysregulation of miRNA in Patients with Parkinson's Disease. Salemi M; Marchese G; Lanza G; Cosentino FII; Salluzzo MG; Schillaci FA; Ventola GM; Cordella A; Ravo M; Ferri R Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614153 [TBL] [Abstract][Full Text] [Related]
8. Modified level of miR-376a is associated with Parkinson's disease. Baghi M; Rostamian Delavar M; Yadegari E; Peymani M; Pozo D; Hossein Nasr-Esfahani M; Ghaedi K J Cell Mol Med; 2020 Feb; 24(4):2622-2634. PubMed ID: 31930701 [TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease. Chen X; Cao W; Zhuang Y; Chen S; Li X Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521 [TBL] [Abstract][Full Text] [Related]
10. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease. Xie S; Niu W; Xu F; Wang Y; Hu S; Niu C Int J Neurosci; 2022 Jul; 132(7):673-688. PubMed ID: 33045885 [TBL] [Abstract][Full Text] [Related]
11. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease. Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients. Tolosa E; Botta-Orfila T; Morató X; Calatayud C; Ferrer-Lorente R; Martí MJ; Fernández M; Gaig C; Raya Á; Consiglio A; Ezquerra M; Fernández-Santiago R Neurobiol Aging; 2018 Sep; 69():283-291. PubMed ID: 29935433 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes. Bao J; Chang W; Zhao Y J Mol Neurosci; 2022 Sep; 72(9):1809-1819. PubMed ID: 35731466 [TBL] [Abstract][Full Text] [Related]
14. Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages. Christodoulou CC; Papanicolaou EZ Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902304 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Miñones-Moyano E; Porta S; Escaramís G; Rabionet R; Iraola S; Kagerbauer B; Espinosa-Parrilla Y; Ferrer I; Estivill X; Martí E Hum Mol Genet; 2011 Aug; 20(15):3067-78. PubMed ID: 21558425 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of gut miRNAs in idiopathic Parkinson's disease. Kurz A; Kumar R; Northoff BH; Wenk C; Schirra J; Donakonda S; Höglinger GU; Schwarz J; Rozanski V; Hübner R; Bötzel K; Holdt LM; Koeglsperger T Parkinsonism Relat Disord; 2021 Jul; 88():46-50. PubMed ID: 34118643 [TBL] [Abstract][Full Text] [Related]
18. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Gui Y; Liu H; Zhang L; Lv W; Hu X Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684 [TBL] [Abstract][Full Text] [Related]
19. A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease. Fazeli S; Motovali-Bashi M; Peymani M; Hashemi MS; Etemadifar M; Nasr-Esfahani MH; Ghaedi K PLoS One; 2020; 15(11):e0240855. PubMed ID: 33171483 [TBL] [Abstract][Full Text] [Related]
20. Common signatures of differential microRNA expression in Parkinson's and Alzheimer's disease brains. Dobricic V; Schilling M; Farkas I; Gveric DO; Ohlei O; Schulz J; Middleton L; Gentleman SM; Parkkinen L; Bertram L; Lill CM Brain Commun; 2022; 4(6):fcac274. PubMed ID: 36382223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]